STEATOBLEPHARON

STEATOBLEPHARON was reported 5 times

STEATOBLEPHARON is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0001
1 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5 0.0000